Skip to main content
OpenTrials

Clinical trial condition

Neoplasms, Nerve Tissue

Explore clinical trials studying Neoplasms, Nerve Tissue. Study availability and eligibility vary by location and protocol.

6,305 public trials 1,294 recruiting studies
Refine in advanced search Browse all conditions

Neoplasms, Nerve Tissue trial results

Completed

MAGE-A10ᶜ⁷⁹⁶T for Urothelial Cancer, Melanoma or Head and Neck Cancers

NCT02989064

Conditions
Bladder Urothelial Carcinoma, Carcinoma, Carcinoma, Transitional Cell, +20 more
Locations
  • Massachusetts General Hospital Boston, Massachusetts, United States
  • Washington University - School of Medicine St Louis, Missouri, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Ohio State University Wexner Medical Center Columbus, Ohio, United States
View Trial Details
Completed

A Study of Multiple Doses of RO7247669 in Participants With Previously Untreated Unresectable or Metastatic Melanoma

NCT05419388

Conditions
Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations
  • Coffs Harbour Health Campus Coffs Harbour, New South Wales, Australia
  • Melanoma Institute Australia North Sydney, New South Wales, Australia
  • Princess Alexandra Hospital Woolloongabba, Queensland, Australia
  • One Clinical Research Nedlands, Western Australia, Australia
View all 22 locations
View Trial Details
Completed

Vestibular Schwannoma Organoids

NCT05786144

Conditions
Cranial Nerve Diseases, Cranial Nerve Neoplasms, Ear Diseases, +19 more
Locations
  • Maastro Maastricht, Limburg, Netherlands
  • Maastricht University Medical Center Maastricht, Limburg, Netherlands
View Trial Details
Completed

Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

NCT01983748

Conditions
Eye Diseases, Eye Neoplasms, Melanoma, +11 more
Locations
  • Dept. of Dermatology, University Hospital Erlangen, Bavaria, Germany
  • University Hospital Department of Ophtalmology Erlangen, Bavaria, Germany
  • University Hospital Department of Ophtalmology Würzburg, Bavaria, Germany
  • Städtisches Klinikum Dessau, Germany
View Trial Details
Completed

Induction Therapy Including 131 I-MIBG and Chemotherapy in Treating Patients With Newly Diagnosed High-Risk Neuroblastoma Undergoing Stem Cell Transplant, Radiation Therapy, and Maintenance Therapy With Isotretinoin

NCT01175356

Conditions
Ganglioneuroblastoma, Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, +13 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
View all 25 locations
View Trial Details
Completed

Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

NCT00336024

Conditions
Anaplastic Medulloblastoma, Glioma, Medulloblastoma, +10 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
View all 145 locations
View Trial Details

Related conditions